Investigative Radiology September 2019

Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?


Can_Virtual_Contrast_Enhancement_in_Brain_MRI, fig 3 excerptObjective:
Gadolinium-based contrast agents (GBCAs) have become an integral part in daily clinical decision making in the last 3 decades. However, there is a broad consensus that GBCAs should be exclusively used if no contrast-free magnetic resonance imaging (MRI) technique is available to reduce the amount of applied GBCAs in patients.

In the current study, we investigate the possibility of predicting contrast enhancement from noncontrast multiparametric brain MRI scans using a deep-learning (DL) architecture.  View/Download

 

Investigative_RadiologyThis article, and specifically a different article each month from the current issue, is made available courtesy of Lippincott Williams & Wilkins, the publisher of Investigative Radiology – for both viewing on the web and download, with the restriction that this is for personal use only. Additional information can be found at www.investigativeradiology.com